Comparison of Oral P2Y12 Inhibitors in Acute Coronary Syndrome

被引：0
|
作者：
Ferracane, Elisa [1 ]
Bartoli, Laura [1 ]
Trippoli, Sabrina [1 ]
Messori, Andrea [1 ]
机构：
[1] Reg Toscana, Via Alderotti 46-N, I-50139 Florence, Italy
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2020年 / 135卷
关键词：
D O I：
10.1016/j.amjcard.2020.08.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis
    Yue Fei
    Cheuk Kiu Lam
    Bernard Man Yung Cheung
    Scientific Reports, 10
  • [32] Effect of new p2y12 inhibitors in patients with chronic kidney disease after an acute coronary syndrome
    Deharo, P.
    Pankert, M.
    Bonnet, G.
    Quilici, J.
    Bonnet, J. L.
    Cuisset, T.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1163 - 1163
  • [33] DURATION AND TIMING OF INITIATION OF THERAPY WITH PLATELET P2Y12 INHIBITORS IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME
    Shalaev, S., V
    Safiullina, Z. M.
    KARDIOLOGIYA, 2018, 58 (03) : 54 - 62
  • [34] Challenges of Combining Opioids and P2Y12 Inhibitors in Acute Coronary Syndrome: Should the Future Be Opioid Free?
    Moore, Catherine H.
    Lukas, Jack G.
    Cave, Brandon E.
    Khouzam, Rami N.
    CURRENT PROBLEMS IN CARDIOLOGY, 2021, 46 (04)
  • [35] Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome
    Kibum Kim
    Daniel R. Touchette
    Larisa H. Cavallari
    Amer K. Ardati
    Robert J. DiDomenico
    Cardiovascular Drugs and Therapy, 2019, 33 : 533 - 546
  • [36] Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis
    Fei, Yue
    Lam, Cheuk Kiu
    Cheung, Bernard Man Yung
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [37] Predictors of newer P2Y12 inhibitors prescription at discharge in a contemporary cohort of patients with acute coronary syndrome
    Gomez-Molina, M.
    Flores-Blanco, P. J.
    Rapodeiras-Rubin, S.
    Abu-Assi, E.
    Cambronero-Sanchez, F.
    Cobas-Paz, R.
    Lopez-Cuenca, A.
    Caneiro-Queija, B.
    Guerrero-Perez, E.
    Valdes, M.
    Iniguez-Romo, A.
    Manzano Fernandez, S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 801 - 801
  • [38] Comparing Measures of Adherence and Persistence to P2Y12 Inhibitors in Acute Coronary Syndromes
    Moon, Jungyeon
    Ozaki, Aya F.
    Chong, Alice
    Sud, Maneesh
    Fang, Jiming
    Austin, Peter C.
    Ko, Dennis T.
    Jackevicius, Cynthia A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 226 : 134 - 136
  • [39] Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis
    Luna Carrillo-Aleman
    Francisco Marín
    José M. Rivera-Caravaca
    Nuria Vicente-Ibarra
    Elena Candela-Sanchez
    Maria A. Esteve-Pastor
    Teresa Lozano
    Miriam Sandín-Rollan
    Vicente Pernias-Escrig
    Manuel Macías
    Miriam Quintana-Giner
    Andrea Veliz
    Esteban Orenes-Piñero
    Juan G. Martínez-Martínez
    Juan M. Ruiz-Nodar
    Clinical Drug Investigation, 2019, 39 : 275 - 283
  • [40] Is Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Clinically Justified? Pretreatment with P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome: An Outdated and Harmful Strategy Response
    Valgimigli, Marco
    CIRCULATION, 2014, 130 (21) : 1914 - 1914
12345